Telix Pharmaceuticals Limited (ASX:TLX)
Australia flag Australia · Delayed Price · Currency is AUD
16.09
+0.51 (3.27%)
Aug 28, 2026, 10:24 AM AEST

Telix Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Dec '22 Dec '21
Net Income
33.5-7.1333.694.21-70.74-58.54
Depreciation & Amortization
22.3220.955.284.163.663.76
Other Amortization
0.660.46----
Asset Writedown & Restructuring Costs
0.570.57-0.480.55--
Stock-Based Compensation
19.3519.3512.935.855.510.96
Other Operating Activities
-43.18-6.2819.0824.0318.7712.59
Change in Accounts Receivable
-20.47-20.47-37.49-18.62-13.55-5.23
Change in Inventory
-7.64-7.64-2.13-6.55-3.41-2.05
Change in Accounts Payable
28.9828.9828.8418.0920.75.44
Change in Unearned Revenue
-9.13-9.13-6.23-3.43-1.91-1.96
Change in Other Net Operating Assets
-36.96-36.96-26.01-14-2.511.89
Operating Cash Flow
-12.01-17.2927.4914.27-43.48-43.14
Operating Cash Flow Growth
--92.60%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Dec '22 Dec '21
Capital Expenditures
-33.48-25.69-9.12-6.31-4.78-0.97
Cash Acquisitions
-12.78-229.03-23.2-1-0.66-
Sale (Purchase) of Intangibles
-1.31-18.08-13.07-0.8-4.64-
Investment in Securities
-1.07-0.89-32.91-8.7--
Other Investing Activities
-12.16-12.22-8.4-0.04-1.47-1.01
Investing Cash Flow
-60.78-285.92-86.69-16.84-11.55-1.98

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Dec '22 Dec '21
Long-Term Debt Issued
-0.53427.94.192.05-
Long-Term Debt Repaid
--6.06-2.06-1.27-0.87-0.68
Net Debt Issued (Repaid)
115.13-5.53425.842.921.18-0.68
Issuance of Common Stock
2.51.810.664.17123.052.75
Other Financing Activities
---9.71--5.31-
Financing Cash Flow
117.63-3.72416.797.09118.922.07

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.098.8-1.890.990.22.4
Net Cash Flow
44.75-298.13355.75.5264.09-40.65

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Dec '22 Dec '21
Free Cash Flow
-45.49-42.9918.377.97-48.26-44.11
Free Cash Flow Growth
--130.64%---
Free Cash Flow Margin
-5.11%-5.35%3.56%2.39%-44.35%-798.67%
Free Cash Flow Per Share
-0.13-0.130.050.03-0.15-0.16
Levered Free Cash Flow
-62.6-36.6753.7141.26-20.88-27.18
Unlevered Free Cash Flow
-53.23-28.0756.7141.58-20.74-27.11

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Jan '24 Dec '22 Dec '21
Cash Interest Paid
14.7913.73.090.390.280.14
Cash Income Tax Paid
32.7521.32.036.86-11.3-8.81
Change in Working Capital
-45.22-45.22-43.01-24.51-0.68-1.91